Venclexta (venetoclax) - Roche, AbbVie
Gazyva (obinutuzumab) - Roche, Biogen
Acute myeloid leukemia arising in treated chronic lymphocytic leukemia/small lymphocytic lymphoma: a challenge in analysis of lineage relationship. (PubMed, J Hematop) - Sep 20, 2026 - "Herein, we report a 75-year-old female with a history of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) post obinutuzumab and venetoclax therapy, presenting with CD4+/CD56+/CD123+ acute myeloid leukemia (AML) with histiocytic morphology. The unusual morphology triggered a preliminary diagnosis of CLL transdifferentiation to histiocytic sarcoma (HS); however, a comprehensive workup led to the correct diagnosis of de novo AML. This case showcases the utility of ancillary studies in the work up of secondary myeloid neoplasms post B-cell lymphomas and underlines pitfalls to consider for accurate characterization of these complex malignancies." 
Journal • Acute Myelogenous Leukemia • B Cell Lymphoma • Chronic Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Sarcoma • Small Lymphocytic Lymphoma • Solid Tumor • CD123 • CD4 • IL3RA • NCAM1
http://www.ncbi.nlm.nih.gov/pubmed/42762392
 
Aruna Rangan; David S Viswanatha; Min Shi; Patricia T Greipp; Paul Ollila; Rong He
 
Sep 20, 2026
 
Prev Next